Target intelligence / Profile preview

Multiple unspecified cellular and enzymatic targets

Molecular classification
Other
01

Overview

The designation 'Multiple unspecified cellular and enzymatic targets' refers to a broad pharmacological category rather than a single, discrete molecular entity (ChEMBL Database, 2024). It is typically used for drugs or chemical agents that exert their effects through non-specific interactions with various proteins, lipids, and enzymes across the cell (Goodman & Gilman's The Pharmacological Basis of Therapeutics). Common examples include antiseptics like ethanol or hydrogen peroxide, which cause widespread protein denaturation and membrane disruption (PubMed, PMID: 11406843). In many cases, this classification is applied when the exact molecular mechanism of a drug is unknown or when its therapeutic action is the result of hitting numerous low-affinity targets simultaneously (DrugBank Online). From a drug development perspective, agents in this category often lack the selectivity required for modern targeted therapies, leading to significant safety concerns and off-target toxicity (StatPearls, 2023). Consequently, these substances are often limited to topical applications or used in situations where broad-spectrum activity is desirable, such as sterilization. For biotech analysts, this entry signifies a complex and often poorly defined mechanism of action that poses challenges for traditional structure-activity relationship (SAR) modeling.

Other names
Non-specific targetsUnspecified targetsUnknown cellular targetsMulti-target mechanism
02

Mechanism of action

Non-specific denaturation of proteins, disruption of lipid membranes, or global inhibition of enzymatic activity through oxidative stress or covalent modification.

03

Biological functions

Other
04

Disease associations

Other
05

Safety considerations

Lack of selectivitySystemic toxicityUnpredictable off-target effectsNon-selective tissue damageDifficulty in establishing a therapeutic window
06

Interacting drugs

Ethanol

5 more in the full profile.

Beyond the preview

Go deeper on Multiple unspecified cellular and enzymatic targets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple unspecified cellular and enzymatic targets.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call